Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business
Wait Pausing Investments
Novo Nordisk
Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business
Wait Pausing InvestmentsRevenue(RF), mln.USD
159
Staff
574
Capital, mln.USD
140
Glob.Revenue, mln.USD
20005
The Company Statement
Suspend further marketing and clinical investment; pause new clinical trials and active enrollment
| April 01, 2022 | https://www.novonordisk.com/news-and-media/critical-updates.html |
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.